LCN2 and Alzheimer disease: Lcn2 was identified as a pan-reactive astrocyte marker in gene expression analyses [38] and we previously showed significant elevations in astrocytic lcn2 levels upon their exposure to oxysterol mixtures that mimic their composition in AD brain [34].